Influence of botulinum toxin on myogenous facial pain;Beeinflussung muskulärer gesichtsschmerzen durch botulinumtoxin A

Schmerz

Volumn 19, Issue 1, 2005, Pages 18-25

  Seedorf, H ^a   Leuwer, R ^a   Bussopulos, A ^a   Fenske, C ^a   Jude H D ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Botulinum toxin; Facial pain; Masticatory muscles; Orofacial pain; Therapy

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FACE PAIN; FEMALE; HUMAN; JAW MOVEMENT; MALE; MANDIBLE; SIDE EFFECT; WILCOXON SIGNED RANKS TEST; CLINICAL TRIAL; DRUG EFFECT; MASTICATORY MUSCLE; PATHOPHYSIOLOGY;

ADULT; BOTULINUM TOXINS; FACIAL PAIN; FEMALE; HUMANS; MALE; MASTICATORY MUSCLES;

EID: 15944367767     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-003-0296-9     Document Type: Article

References (45)

1. De Andres J, Cerda-Olmedo G, Valia JC, Monsalve V, Lopez-Alarcon, Minguez A (2003) Use of botulinum toxin in the treatment of chronic myofascial pain. Clin J Pain 19:269-275
2. Birch L, Christensen H, Arendt-Nielsen L, Graven-Nielsen T, Sogaard K (2000) The influence of experimental muscle pain on motor unit activity during low-level contraction. Eur J Appl Physiol 83:200-206
3. McCarroll RS, Hesse JR, Naeije M, Yoon CK, Hansson TL (1987) Mandibular border positions and their relationships with peripheral joint mobility. J Oral Rehabil 14:125-131
4. Conti PC, dos Santos CN, Lauris JR (2002) Interexaminer agreement for muscle palpation procedures: the efficacy of a calibration program. Cranio 20:289-294
5. Drechsel U, Gerbershagen HU (1992) Gesichtsund Kopfschmerzen aus der Sicht des Schmerztherapeuten. In: Siebert GK (Hrsg) Gesichts- und Kopf-schmerzen. Ein interdisziplinärer Überblick für Mediziner, Zahnmediziner und Psychologen. Hanser, München, S 171
6. Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW (2002) Treatment of headache with botulinum toxin A-a review according to evidence-based medicine criteria. Cephalalgia 22:699-710
7. Freesmeyer WB (1987) Funktionelle Befunde im orofazialen System und deren Wechselwirkungen. Hanser, München, S 33
8. Freesmeyer WB (1993) Zahnärztliche Funktionstherapie. Hanser, München, S 41
9. Freund B, Schwanz M, Symington JM (1999) The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 57:916-920
10. Göbel H, Jost WH (2003) Arbeitsgruppe Schmerz im Arbeitskreis Botulinumtoxin der Deutschen Gesellschaft für Neurologie. Botulinumtoxin in der spezifischen Schmerztherapie. Schmerz 17:149-165
11. Graber G (1981) Die Funktionsstörung im stomatognathen System und ihre Prophylaxe. Zahnärztl Prax 32:282-284
12. Greene CS, Laskin DM (1971) Meprobamate therapy for the myofascial pain-dysfunction (MPD) syndrome: a double-blind evaluation. J Am Dent Assoc: 587-590
13. Harkins S, Linford J, Cohen J, Kramer T, Cueva L (1991) Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double blind study. J Craniomandib Disord 5:179
14. Hugger A et al. (2002) Untersucherkalibrierung für eine multizentrische Studie zur Therapie von CMD-Patienten. Dtsch Zahnärztl Z 57:13
15. Jagger RG (1973) Diazepam in the treatment of temporomandibular joint dysfunction syndrome - a double blind study. J Dent 2:37-40
16. Johansson H, Sojka P (1991) Pathophysiological mechanisms involved in genesis and spread of muscular tension in occupational muscle pain and in chronic musculoskeletal pain syndromes: a hypothesis. Med Hypotheses 35:196-203
17. Kiss I (2000) Placebo. Schmerz 14:252-256
18. Lang AM (2002) Botulinum toxin therapy for myofascial pain disorders. Curr Pain Headache Rep 6:355-360
19. Laskin DM (1969) Etiology of the pain-dysfunction syndrome. J Am Dent Assoc 79:141-153
20. Von Lindern JJ, Niederhagen B, Berge S, Appel T (2003) Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg. 61:774-778
21. Lindroth JE, Schmidt JE, Carlson CR (2002) A comparison between masticatory muscle pain patients and intracapsular pain patients on behavioral and psychosocial domains. J Orofac Pain Fall 16:277-283
22. Liu ZJ, Yamagata K, Kasahara Y, Ito G (1999) Electromyographic examination of jaw muscles in relation to symptoms and occlusion of patients with temporomandibular joint disorders. J Oral Rehabil 26:33-47
23. Lund JP, Donga R, Widmer CG, Stohler CS (1991) The pain-adaptation model: a discussion of the relationship between chronic musculoskeletal pain and motor activity. Can J Physiol Pharmacol 69:683-694
24. Møller E (1985) Muscle hyperactivity leads to pain and dysfunction. In: Klineberg I, Sessle B (eds) Orofacial pain and neuromuscular dysfunction. Pergamon, Oxford, pp 69-92
25. Manns A, Miralles R, Cumsille F (1985) Influence of vertical dimension on masseter muscle electromyographic activity in patients with mandibular dysfunction. J Prosthet Dent 53:243-247
26. Marbach JJ, Wallenstein SL (1988) Analgesic, mood and hemodynamic effects of intranasal cocaine and lidocaine in chronic facial pain of deafferentation and myofacial origin. J Pain Symptom Manage 3:73-79
27. McMillan AS, Nolan A, Kelly PJ (1997) The efficacy of dry needling and Procaine in the treatment of myofascial pain in the jaw muscles. J Orofac Pain 11:307-310
28. Nixdorf DR, Heo G, Major PW (2002) Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. J Orofac Pain 16:277-283
29. Ott RW (1985) Über die Reaktionen der Kaumuskulatur auf okklusal bedingte Funktionsstörungen. Eine elektromyographische Studie. Dtsch Zahnärztl Z 40:211-217
30. Palla S (2002) Grundsätze zur Therapie des myoarthropathischen Schmerzes. Schmerz 16:373-381
31. Park SJ, Chiang CY, Hu JW, Sessle BJ (2001) Neuroplasticity induced by tooth pulp stimulation in trigeminal subnucleus oralis involves NMDA receptor mechanisms. J Neurophysiol 85:1836-1846
32. Peschen-Rosin R (2002) Gesichtsschmerzen in der Psychiatrie. Differentialdiagnosen und therapeutische Empfehlungen. Schmerz 16:395-403
33. Ramfjord SP (1961) Bruxism, a clinical and elektromyographic study. J Am Dent Assoc 62:21-44
34. Ro JY, Svensson P, Capra N (2002) Effects of experimental muscle pain on electromyographic activity of masticatory muscles in the rat. Muscle Nerve 25:576-584
35. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R (1987) The analgesic effect of amitriptyline. J Orofac Pain: 31:199-209
36. Schinder HJ, Türp JC (2002) Kiefermuskelschmerz - Neurobiologische Grundlagen. Sehmerz 16:346-355
37. Simons DG (1996) Clinical and etiological update of myofascial pain from trigger points. J Musculoskelet Pain 4:93-121
38. Sommer C (2003) Pharmakologische Behandlung orofazialer Schmerzen. Schmerz 16:346-355
39. Stauber WT, Clarkson PM, Fritz VK, Evans WJ (1990) Extracellular matrix disruption and pain after eccentric muscle action. J Appl Physiol 69:868-874
40. Stohler CS (1999) Craniofacial pain and motor function: pathogenesis, clinical correlates, and implications. Crit Rev Oral Biol Med 10:504-518
41. Svensson P, Arendt-Nielsen L (1996) Effects of 5 days of repeated submaximal clenching on masticatory muscle pain and tenderness: an experimental study. J Orofac Pain 10:330-338
42. Svensson P, Graven-Nielsen T, Matre D, Arendt-Nielsen L (1998) Experimental muscle pain does not cause long-lasting increases in resting electromyographic activity. Muscle Nerve 21:1382-1389
43. Travell J, Rinzler S, Herman M (1942) Pain and disability of the shoulder and arm. Treatment by intramuscular infiltration with procaine hydrochloride. J Am Med Assoc 120:417-422
44. Türp JC, Schindler HJ, Pritsch M, Rong Q (2002) Antero-posterior activity changes in the superficial masseter muscle after exposure to experimental pain. Eur J Oral Sci 110:83-91
45. Türp JC (2002) Orofazialer Schmerz. Schmerz 16:337-338